Product Description
Product introduction
Fabiflu Tablet is an antiviral medicine. It is used for the treatment of mild to moderate coronavirus disease (COVID-19) in adults. It stops the virus from multiplying and therefore, decreases the viral load in the body.
Take Fabiflu Tablet only as per the dose and duration suggested by your doctor. Do not self-medicate. The most common side effects of this medicine include the increased uric acid levels in blood, diarrhea, decreased white blood cell count (neutrophils), and increased liver enzymes. If any of these side effects bother you, consult with your doctor.
To make sure it is safe for you, you should let your doctor know if you have severe kidney or liver disease before taking this medicine. Fabiflu Tablet is not recommended for women who are pregnant, suspected to be pregnant or breastfeeding, as it can cause harmful effects to the developing baby. Also, inform your doctor if you have a history of hypersensitivity to this drug, have abnormalities in uric acid metabolism, or have gout.
Emergency Use in COVID-19 TreatmentFabiFlu Favipiravir 200 mg Tablets are specifically indicated for adults with mild to moderate COVID-19, offering a crucial therapeutic option during the pandemic. The medication must be used strictly under a doctor's direction and is part of India's emergency response, only available via prescription following DCGI approval. Each dosage helps inhibit viral replication, supporting patient recovery.
Effectiveness and Safety MeasuresStrict guidelines ensure FabiFlu is both effective and safe. Favipiravir is prescribed in carefully monitored doses and includes regular assessment by healthcare professionals. Side effects can include diarrhea, elevated liver enzymes, and decreased neutrophil count. Usage is not recommended for certain groups, such as pregnant or breastfeeding women, reflecting its restricted emergency authorization.
Proper Usage and Storage GuidelinesTo maintain efficacy, FabiFlu tablets should be stored in a cool, dry environment below 30C, away from sunlight. The medication should be taken orally, with or without food, as prescribed by a physician. Patients should complete the full course as directed and consult medical professionals regarding any adverse reactions.
FAQ's of FabiFlu Favipiravir 200 mg Tablets:
Q: How should FabiFlu Favipiravir 200 mg Tablets be taken for COVID-19 treatment?
A: FabiFlu should be taken orally as directed by your physician, typically starting with 1800 mg twice daily on the first day, followed by 800 mg twice daily. Always follow your doctor's instructions and complete the full prescribed course.
Q: What are the primary benefits of using FabiFlu Favipiravir during a COVID-19 infection?
A: FabiFlu is designed to help inhibit the replication of the SARS-CoV-2 virus, potentially reducing viral load and aiding in the recovery of adults with mild to moderate COVID-19 symptoms under medical supervision.
Q: When is FabiFlu prescribed and who is eligible to use it?
A: FabiFlu is prescribed for emergency use in adults diagnosed with mild to moderate COVID-19 infection. It is not recommended for use in pregnant or breastfeeding women or children and should only be taken under a physician's supervision.
Q: What precautions should be followed while using FabiFlu Favipiravir tablets?
A: Patients should inform their doctor about all existing medical conditions. The tablets should be stored below 30C, away from moisture and sunlight, and only be taken according to the prescribed dosage. Pregnant and breastfeeding women should avoid this medication.
Q: What are the potential side effects of FabiFlu?
A: Possible side effects include diarrhea, elevated liver enzymes, and a decreased neutrophil count. If you experience unusual or severe symptoms, contact a healthcare professional immediately.
Q: Where can I obtain FabiFlu Favipiravir tablets?
A: FabiFlu is available by prescription only and distributed by authorized pharmacies and healthcare providers across India. It cannot be purchased over the counter and must be prescribed by a licensed physician.